A public-places tobacco-smoking ban in the Swiss canton of Ticino will cover many administrative, recreational and transport facilities.
Taken on its own, the idea that the science underlying regulations should be made publicly available in a manner sufficient for independent validation cannot be faulted.
A tobacco- and nicotine-product control-bill is being put out for public comment in South Africa.
A court challenge by tobacco manufacturers to regulations imposed in Kenya is aimed in part at a requirement that they contribute two percent of their revenues to a consolidated fund.
Tobacco distributors in the US will have to pay particular attention to their record keeping as an existing law is enforced more aggressively.
A suggestion has been made that cigarette packs in the UK should be used as a promotional vehicle to steer smokers away from smoking and toward vaping.
One of the lessons to come out of the JUUL affair is that it can be dangerous to come up with a product that is ‘too’ successful.
Elephant Mountain, which is to be declared a tobacco-smoke-free zone is an ideal spot to take photos of the Taipei skyline – on a clear day, presumably.
Does the US Food and Drug Administration know what it’s doing? Presumably yes. Do its actions always promote public health? Apparently not. Is this concerning? It would seem so.
The US Food and Drug Administration seems intent on heaping some of the blame for ‘underage sales’ on the product being sold. This is like blaming a car for a speeding offence.